Eric R Tkaczyk1,2,3, Joseph R Coco4, Jianing Wang5, Fuyao Chen1,2,3, Cheng Ye5, Madan H Jagasia6, Benoit M Dawant3,5, Daniel Fabbri4,5. 1. Department of Veterans Affairs, Tennessee Valley Health System, Nashville, Tennessee. 2. Department of Dermatology, Vanderbilt Cutaneous Imaging Clinic, Vanderbilt University Medical Center, Nashville, Tennessee. 3. Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee. 4. Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee. 5. Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, Tennessee. 6. Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Abstract
BACKGROUND: Estimating the extent of affected skin is an important unmet clinical need both for research and practical management in many diseases. In particular, cutaneous burden of chronic graft-vs-host disease (cGVHD) is a primary outcome in many trials. Despite advances in artificial intelligence and 3D photography, progress toward reliable automated techniques is hindered by limited expert time to delineate cGVHD patient images. Crowdsourcing may have potential to provide the requisite expert-level data. MATERIALS AND METHODS: Forty-one three-dimensional photographs of three cutaneous cGVHD patients were delineated by a board-certified dermatologist. 410 two-dimensional projections of the raw photos were each annotated by seven crowd workers, whose consensus performance was compared to the expert. RESULTS: The consensus delineation by four of seven crowd workers achieved the highest agreement with the expert, measured by a median Dice index of 0.7551 across all 410 images, outperforming even the best worker from the crowd (Dice index 0.7216). For their internal agreement, crowd workers achieved a median Fleiss's kappa of 0.4140 across the images. The time a worker spent marking an image had only weak correlation with the surface area marked, and very low correlation with accuracy. Percent of pixels selected by the consensus exhibited good correlation (Pearson R = 0.81) with the patient's affected surface area. CONCLUSION: Crowdsourcing may be an efficient method for obtaining demarcations of affected skin, on par with expert performance. Crowdsourced data generally agreed with the current clinical standard of percent body surface area to assess cGVHD severity in the skin. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Estimating the extent of affected skin is an important unmet clinical need both for research and practical management in many diseases. In particular, cutaneous burden of chronic graft-vs-host disease (cGVHD) is a primary outcome in many trials. Despite advances in artificial intelligence and 3D photography, progress toward reliable automated techniques is hindered by limited expert time to delineate cGVHD patient images. Crowdsourcing may have potential to provide the requisite expert-level data. MATERIALS AND METHODS: Forty-one three-dimensional photographs of three cutaneous cGVHDpatients were delineated by a board-certified dermatologist. 410 two-dimensional projections of the raw photos were each annotated by seven crowd workers, whose consensus performance was compared to the expert. RESULTS: The consensus delineation by four of seven crowd workers achieved the highest agreement with the expert, measured by a median Dice index of 0.7551 across all 410 images, outperforming even the best worker from the crowd (Dice index 0.7216). For their internal agreement, crowd workers achieved a median Fleiss's kappa of 0.4140 across the images. The time a worker spent marking an image had only weak correlation with the surface area marked, and very low correlation with accuracy. Percent of pixels selected by the consensus exhibited good correlation (Pearson R = 0.81) with the patient's affected surface area. CONCLUSION: Crowdsourcing may be an efficient method for obtaining demarcations of affected skin, on par with expert performance. Crowdsourced data generally agreed with the current clinical standard of percent body surface area to assess cGVHD severity in the skin. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Mary E D Flowers; Jane F Apperley; Koen van Besien; Ahmet Elmaagacli; Andrew Grigg; Vijay Reddy; Andrea Bacigalupo; Hans-Jochem Kolb; Luis Bouzas; Mauricette Michallet; H Miles Prince; Robert Knobler; Dennis Parenti; Jose Gallo; Hildegard T Greinix Journal: Blood Date: 2008-07-11 Impact factor: 22.113
Authors: Steven Z Pavletic; Paul Martin; Stephanie J Lee; Sandra Mitchell; David Jacobsohn; Edward W Cowen; Maria L Turner; Gorgun Akpek; Andrew Gilman; George McDonald; Mark Schubert; Ann Berger; Peter Bross; Jason W Chien; Daniel Couriel; J P Dunn; Jane Fall-Dickson; Ann Farrell; Mary E D Flowers; Hildegard Greinix; Steven Hirschfeld; Lynn Gerber; Stella Kim; Robert Knobler; Peter A Lachenbruch; Frederick W Miller; Barbara Mittleman; Esperanza Papadopoulos; Susan K Parsons; Donna Przepiorka; Michael Robinson; Michael Ward; Bryce Reeve; Lisa G Rider; Howard Shulman; Kirk R Schultz; Daniel Weisdorf; Georgia B Vogelsang Journal: Biol Blood Marrow Transplant Date: 2006-03 Impact factor: 5.742
Authors: Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers Journal: Biol Blood Marrow Transplant Date: 2005-12 Impact factor: 5.742
Authors: Sandra A Mitchell; David Jacobsohn; Kimberly E Thormann Powers; Paul A Carpenter; Mary E D Flowers; Edward W Cowen; Mark Schubert; Maria L Turner; Stephanie J Lee; Paul Martin; Michael R Bishop; Kristin Baird; Javier Bolaños-Meade; Kevin Boyd; Jane M Fall-Dickson; Lynn H Gerber; Jean-Pierre Guadagnini; Matin Imanguli; Michael C Krumlauf; Leslie Lawley; Li Li; Bryce B Reeve; Janine Austin Clayton; Georgia B Vogelsang; Steven Z Pavletic Journal: Biol Blood Marrow Transplant Date: 2011-04-12 Impact factor: 5.742
Authors: Jeanne M Palmer; Stephanie J Lee; Xiaoyu Chai; Barry E Storer; Mary E D Flowers; Kirk R Schultz; Yoshihiro Inamoto; Corey Cutler; Joseph Pidala; Mukta Arora; David A Jacobsohn; Paul A Carpenter; Steven Z Pavletic; Paul J Martin Journal: Biol Blood Marrow Transplant Date: 2012-06-09 Impact factor: 5.742
Authors: David A Jacobsohn; Allen R Chen; Marianna Zahurak; Steven Piantadosi; Viki Anders; Javier Bolaños-Meade; Meghan Higman; Jeffrey Margolis; Michele Kaup; Georgia B Vogelsang Journal: J Clin Oncol Date: 2007-09-20 Impact factor: 44.544
Authors: Hildegard T Greinix; David Pohlreich; Jacqueline Maalouf; Peter Soukup; Volker Supper; Peter Kalhs; Robert M Knobler Journal: Biol Blood Marrow Transplant Date: 2007-04-23 Impact factor: 5.742
Authors: Hadir Shakshouk; Eric R Tkaczyk; Edward W Cowen; Rokea A El-Azhary; Shahrukh K Hashmi; Saad J Kenderian; Julia S Lehman Journal: Transplant Cell Ther Date: 2021-06-06